Indication
Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
2 clinical trials
4 products
4 drugs
Clinical trial
A Phase II Trial of Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell LymphomaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
IfosfamideProduct
LenalidomideDrug
TafasitamabDrug
AN0025Product
EtoposideClinical trial
A Phase I/II Open Label, Single Center, Study of the Combination of ALX148, Rituximab and Lenalidomide in Patients With Indolent and Aggressive B-Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2026-03-10
Product
CD47 Antagonist ALX148Drug
lenalidomideDrug
Varlilumab